Neuraltus Pharmaceuticals, Inc.

Neuraltus Pharmaceuticals, Inc. logo
🇺🇸United States
Ownership
Private
Established
2004-01-01
Employees
1
Market Cap
-
Website
http://www.neuraltus.com

Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation

Phase 2
Completed
Conditions
Interventions
First Posted Date
2016-06-09
Last Posted Date
2018-05-07
Lead Sponsor
Neuraltus Pharmaceuticals, Inc.
Target Recruit Count
138
Registration Number
NCT02794857
Locations
🇺🇸

University of California, Irvine, Department of Neurology, Orange, California, United States

🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

🇺🇸

University of Miami Miller School of Medicine, Miami, Florida, United States

and more 19 locations

A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Phase 2
Completed
Conditions
Interventions
First Posted Date
2011-01-24
Last Posted Date
2012-11-22
Lead Sponsor
Neuraltus Pharmaceuticals, Inc.
Target Recruit Count
136
Registration Number
NCT01281631
Locations
🇺🇸

University of Kansas Medical Center, Landon Center on Aging, Kansas City, Kansas, United States

🇺🇸

Massachusetts General Hospital, Charlestown, Massachusetts, United States

🇺🇸

Columbia University, New York, New York, United States

and more 14 locations

Single-Ascending-Dose Safety/Tolerability of NP001 in Amyotrophic Lateral Sclerosis (ALS)

Phase 1
Completed
Conditions
Interventions
First Posted Date
2010-03-23
Last Posted Date
2010-10-06
Lead Sponsor
Neuraltus Pharmaceuticals, Inc.
Target Recruit Count
56
Registration Number
NCT01091142
Locations
🇺🇸

University of Kansas Medical Center - Landon Center on Aging, Kansas City, Kansas, United States

🇺🇸

California Pacific Medical Center, San Francisco, California, United States

🇺🇸

Department of Neurology; University of Kentucky Medical Center, Lexington, Kentucky, United States

Study of NP002 in Subjects With Idiopathic Parkinson's Disease to Treat Dyskinesias Due to Levodopa Therapy

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-08-13
Last Posted Date
2011-10-05
Lead Sponsor
Neuraltus Pharmaceuticals, Inc.
Target Recruit Count
65
Registration Number
NCT00957918
Locations
🇺🇸

Strurers Parkinson's Center, Golden Valley, Minnesota, United States

🇺🇸

Barrow Neurology Clinics at St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States

🇺🇸

Keck/USC School of Medicine -Department of Neurology, Los Angelis, California, United States

and more 9 locations
© Copyright 2024. All Rights Reserved by MedPath